BioCentury
ARTICLE | Management Tracks

Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more

July 11, 2020 12:14 AM UTC

Akcea Therapeutics Inc. (NASDAQ:AKCA) said William Andrews will succeed Louis O’Dea as CMO. Andrews joins the rare disease company from Acer Therapeutics Inc. (NASDAQ:ACER), where he was CMO.

Rare disease company Strongbridge Biopharma plc (NASDAQ:SBBP) said Executive Chairman John Johnson will also serve as CEO. Former President and CEO Matthew Pauls stepped down in November...